Patents Assigned to TREFOIL THERAPEUTICS, INC.
  • Recombinant modified fibroblast growth factors and therapeutic uses thereof
    Patent number: 11479591
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: October 25, 2022
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Jennifer Jenkins-Eveleth, Amuthakannan Subramaniam, Ralph Bradshaw
  • Modified fibroblast growth factors for the treatment of ocular disorders
    Patent number: 11103553
    Abstract: Described herein are modified fibroblast growth factors (FGFs), pharmaceutical compositions, ophthalmic formulations, and medicaments that include such modified FGFs, and methods of using such modified FGFs to treat ocular diseases, disorders, or conditions.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: August 31, 2021
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Kenneth A. Thomas, Jr.